المؤلفون: Heloury Y., Leclair M.-D.

مصطلحات الفهرس: drug release, enuresis/dt [Drug Therapy], feedback system, flushing, human, incontinence, micturition, micturition disorder, neurogenic bowel, overactive bladder/dt [Drug Therapy], pelvic floor muscle training, postvoid residual urine volume, priority journal, review, side effect/si [Side Effect], sphincter, stress incontinence, urinary tract disease, urine incontinence/dt [Drug Therapy], urine incontinence/pc [Prevention], xerostomia/si [Side Effect], alfuzosin/do [Drug Dose], alfuzosin/pd [Pharmacology], alpha adrenergic receptor blocking agent/pd [Pharmacology], botulinum toxin A/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], methylphenidate, nitrofurantoin/cb [Drug Combination], nitrofurantoin/dt [Drug Therapy], oxybutynin/ae [Adverse Drug Reaction], oxybutynin/cm [Drug Comparison], oxybutynin/pr [Pharmaceutics], oxybutynin/pk [Pharmacokinetics], oxybutynin/pd [Pharmacology], placebo, propiverine/dt [Drug Therapy], tolterodine/cm [Drug Comparison], tolterodine/pr [Pharmaceutics], tolterodine/pk [Pharmacokinetics], tolterodine/pd [Pharmacology], trimethoprim/dt [Drug Therapy], trospium chloride/dt [Drug Therapy], trospium chloride/pd [Pharmacology], unclassified drug, dysfunctional elimination syndrome, extraordinary daytime urinary frequency, hinman syndrome, postvoid dribbling, doxazocin/do [Drug Dose], doxazocin/pd [Pharmacology], giggle incontinence/dt [Drug Therapy], antibiotic prophylaxis, anticholinergic effect, bladder contraction, bladder disease, bladder dysfunction, bladder filling, bladder instability/dt [Drug Therapy], constipation/si [Side Effect], detrusor muscle, disease association, disease severity, drug dose increase, drug efficacy, drug formulation, Review

URL: Click here for full text options
LibKey Link

المؤلفون: Heloury Y., Leclair M.-D.

مصطلحات الفهرس: drug release, enuresis/dt [Drug Therapy], feedback system, flushing, human, incontinence, micturition, micturition disorder, neurogenic bowel, overactive bladder/dt [Drug Therapy], pelvic floor muscle training, postvoid residual urine volume, priority journal, review, side effect/si [Side Effect], sphincter, stress incontinence, urinary tract disease, urine incontinence/dt [Drug Therapy], urine incontinence/pc [Prevention], xerostomia/si [Side Effect], alfuzosin/do [Drug Dose], alfuzosin/pd [Pharmacology], alpha adrenergic receptor blocking agent/pd [Pharmacology], botulinum toxin A/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], methylphenidate, nitrofurantoin/cb [Drug Combination], nitrofurantoin/dt [Drug Therapy], oxybutynin/ae [Adverse Drug Reaction], oxybutynin/cm [Drug Comparison], oxybutynin/pr [Pharmaceutics], oxybutynin/pk [Pharmacokinetics], oxybutynin/pd [Pharmacology], placebo, propiverine/dt [Drug Therapy], tolterodine/cm [Drug Comparison], tolterodine/pr [Pharmaceutics], tolterodine/pk [Pharmacokinetics], tolterodine/pd [Pharmacology], trimethoprim/dt [Drug Therapy], trospium chloride/dt [Drug Therapy], trospium chloride/pd [Pharmacology], unclassified drug, dysfunctional elimination syndrome, extraordinary daytime urinary frequency, hinman syndrome, postvoid dribbling, doxazocin/do [Drug Dose], doxazocin/pd [Pharmacology], giggle incontinence/dt [Drug Therapy], antibiotic prophylaxis, anticholinergic effect, bladder contraction, bladder disease, bladder dysfunction, bladder filling, bladder instability/dt [Drug Therapy], constipation/si [Side Effect], detrusor muscle, disease association, disease severity, drug dose increase, drug efficacy, drug formulation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30904
LibKey Link